Breaking News

Catalent Expands Nasal Drug Development and Manufacturing Capabilities

Marks the first phase of a multi-million-dollar investment at the site in Morrisville, NC.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Contract development and manufacturing organization (CDMO) Catalent, has completed a significant expansion of its nasal capabilities at its Morrisville, Research Triangle Park (RTP), NC, facility, to provide world-class services for the development and manufacturing of unit and bi-dose nasal spray products. This marks the first phase of a multi-million-dollar investment at the site to expand and modernize its nasal drug delivery capabilities, increasing technology and capacity to support project...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters